Case Study: Pearl Therapeutics, Inc. achieves faster, more efficient document reviews with Ideagen's PleaseReview

Pearl improves operational efficiency with PleaseReview

Pearl Therapeutics, an AstraZeneca group company developing respiratory therapeutics, faced slow, error-prone review of clinical and regulatory documents. Authors emailed draft copies to multiple reviewers who edited in parallel, creating version-control problems, conflicting comments and labor-intensive manual collation across repeated review cycles.

Implementing PleaseReview across Regulatory Affairs, Clinical Operations, Biostatistics, Analytical Science, Pharmaceutical and Product Development, and Quality Systems gave Pearl real-time collaborative review, centralized version control and visibility of reviewer interactions. The result was fewer review cycles, faster document turnaround, significantly reduced time spent collating changes, and positive user feedback as authors focus more on content than formatting.

Pearl Therapeutics, Inc.

Matt Fitzpatrick

Manager Regulatory Affairs